Dr. Susana Banerjee
Claim this profileThe Royal Marsden NHS Foundation Trust
Expert in Ovarian Cancer
Studies Fallopian Tube Cancer
18 reported clinical trials
27 drugs studied
Area of expertise
1Ovarian Cancer
Global LeaderFRα positive
Stage IV
BRCA positive
2Fallopian Tube Cancer
FRα positive
BRCA positive
BRCA2 negative
Clinical Trials Susana Banerjee is currently running
Ceralasertib + Olaparib/Durvalumab
for Gynecological Cancers
ATARI trial tests the ATR inhibitor drug ceralasertib (AZD6738) alone and in combination with either a PARP inhibitor drug called olaparib, or an anti-PD-L1 immunotherapy called durvalumab (MEDI4736) in patients with relapsed gynaecological cancers to assess the response in groups of patients selected based on their cancer cell subtype and the presence of an abnormality in the ARID1A gene.
Recruiting3 awards Phase 26 criteria
CPI-0209
for Cancer and Lymphoma
First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas. CPI-0209 is a small molecule inhibitor of EZH2.
Recruiting1 award Phase 1 & 28 criteria
More about Susana Banerjee
Clinical Trial Related4 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Susana Banerjee has experience with
- Olaparib
- Topotecan
- Carboplatin
- Paclitaxel
- Defactinib
- Mirvetuximab Soravtansine
Breakdown of trials Susana Banerjee has run
Ovarian Cancer
Fallopian Tube Cancer
Ovarian Tumors
Peritoneal Carcinoma
- Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma
- Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)
- SL-172154 Combination Therapy for Ovarian Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Susana Banerjee specialize in?
Susana Banerjee focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved FRα positive patients, or patients who are Stage IV.
Is Susana Banerjee currently recruiting for clinical trials?
Yes, Susana Banerjee is currently recruiting for 5 clinical trials in Sutton Surrey. If you're interested in participating, you should apply.
Are there any treatments that Susana Banerjee has studied deeply?
Yes, Susana Banerjee has studied treatments such as Olaparib, Topotecan, Carboplatin.
What is the best way to schedule an appointment with Susana Banerjee?
Apply for one of the trials that Susana Banerjee is conducting.
What is the office address of Susana Banerjee?
The office of Susana Banerjee is located at: The Royal Marsden NHS Foundation Trust, Sutton, Surrey SM2 5PT United Kingdom. This is the address for their practice at the The Royal Marsden NHS Foundation Trust.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.